GPRASP蛋白是造血干细胞移植的关键负调控因子
该研究报道G蛋白偶联受体相关分选蛋白(GPRASPs)是造血干细胞移植(HSCT)的负调控因子。沉默Gprasp1或Gprasp2可提高移植后造血干/祖细胞的存活、静息、迁移、龛滞留及造血重建活性,机制涉及GPRASP1/2促进CXCR4降解,Gprasp缺陷细胞中CXCR4积聚增强移植后功能。
要点
- 沉默Gprasp1或Gprasp2增强移植后HSPC的存活、静息、迁移和造血重建活性。
- GPRASP1和GPRASP2促进CXCR4降解,Gprasp缺陷HSPC中CXCR4积聚。
- 破坏GPRASP/CXCR4相互作用未来或可提高HSCT效率。
核心结论
- GPRASP蛋白是HSCT和CXCR4活性的负调控因子,破坏GPRASP/CXCR4相互作用未来或可增强HSCT效率。
研究设计与样本
- 研究采用基因沉默(Gprasp1或Gprasp2)在移植后造血干/祖细胞中评估功能,未报告样本量。
主要发现
- 沉默Gprasp1或Gprasp2增加移植后HSPC的存活、静息、迁移、龛滞留和造血重建活性。
- GPRASP1和GPRASP2促进CXCR4降解,Gprasp缺陷HSPC中CXCR4积聚并增强移植后功能。
临床怎么用
- 未来或可通过破坏GPRASP/CXCR4相互作用提高HSCT效率,目前尚属临床前探索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hematopoietic stem cell (HSC) transplantation (HSCT) is often exploited to treat hematologic disease. Donor HSCs must survive, proliferate, and differentiate in the damaged environment of the reconstituting niche. Illuminating molecular mechanisms regulating the activity of transplanted HSCs will inform efforts to improve HSCT. Here, we report that G-protein-coupled receptor-associated sorting proteins (GPRASPs) function as negative regulators of HSCT. Silencing of Gprasp1 or Gprasp2 increased the survival, quiescence, migration, niche retention, and hematopoietic repopulating activity of hematopoietic stem and progenitor cells (HSPCs) posttransplant. We further show that GPRASP1 and GPRASP2 promote the degradation of CXCR4, a master regulator of HSC function during transplantation. CXCR4 accumulates in Gprasp-deficient HSPCs, boosting their function posttransplant. Thus, GPRASPs negatively regulate CXCR4 stability in HSCs. Our work reveals GPRASP proteins as negative regulators of HSCT and CXCR4 activity. Disruption of GPRASP/CXCR4 interactions could be exploited in the future to enhance the efficiency of HSCT.
引用
- Morales-Hernández A, Benaksas C, Chabot A, et al. GPRASP proteins are critical negative regulators of hematopoietic stem cell transplantation. Blood. 2020. PMID: 32027737. doi:10.1182/blood.2019003435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。